4.7 Article

Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD

Journal

NEUROLOGY
Volume 82, Issue 16, Pages 1455-1462

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000000335

Keywords

-

Funding

  1. NIH: National Institute on Aging [R01 032990, R01 AG018023, AG025711, AG017216, AG003949]
  2. NIH: Mayo Alzheimer's Disease Research Center [P50 AG016574]
  3. NIH: Mayo Alzheimer's Disease Patient Registry [U01 AG006576]
  4. Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program
  5. Palumbo Professorship in Alzheimer's Disease Research
  6. GHR Foundation

Ask authors/readers for more resources

Objective:To investigate association of genetic risk factors for late-onset Alzheimer disease (LOAD) with risk of posterior cortical atrophy (PCA), a syndrome of visual impairment with predominant Alzheimer disease (AD) pathology in posterior cortical regions, and with risk of posterior AD neuropathology.Methods:We assessed 81 participants with PCA diagnosed clinically and 54 with neuropathologic diagnosis of posterior AD vs 2,523 controls for association with 11 significant single nucleotide polymorphisms (SNPs) from published LOAD risk genome-wide association studies.Results:There was highly significant association with APOE epsilon 4 and increased risk of PCA (p = 0.0003, odds ratio [OR] = 3.17) and posterior AD (p = 1.11 x 10(-17), OR = 6.43). No other locus was significant after corrections for multiple testing, although rs11136000 near CLU (p = 0.019, OR = 0.60) and rs744373 near BIN1 (p = 0.025, OR = 1. 63) associated nominally significantly with posterior AD, and rs3851179 at the PICALM locus had significant association with PCA (p = 0.0003, OR = 2.84). ABCA7 locus SNP rs3764650, which was also tested under the recessive model because of Hardy-Weinberg disequilibrium, also had nominally significant association with PCA risk. The direction of association at APOE, CLU, and BIN1 loci was the same for participants with PCA and posterior AD. The effects for all SNPs, except rs3851179, were consistent with those for LOAD risk.Conclusions:We identified a significant effect for APOE and nominate CLU, BIN1, and ABCA7 as additional risk loci for PCA and posterior AD. Our findings suggest that at least some of the genetic risk factors for LOAD are shared with these atypical conditions and provide effect-size estimates for their future genetic studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Neurosciences

Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies

Alexis Moscoso, Melissa C. Wren, Tammaryn Lashley, Erik Arstad, Melissa E. Murray, Nick C. Fox, Kerstin Sander, Michael Scholl

MOLECULAR NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43

Yi Xiao Jiang, Qin Cao, Michael R. Sawaya, Romany Abskharon, Peng Ge, Michael DeTure, Dennis W. Dickson, Janine Y. Fu, Rachel R. Ogorzalek Loo, Joseph A. Loo, David S. Eisenberg

Summary: This study found that amyloid fibrils in FTLD-TDP patients are formed by TMEM106B protein rather than TDP-43 protein. In addition, abundant non-fibrillar aggregated TDP-43 protein was observed.

NATURE (2022)

Article Multidisciplinary Sciences

A computational model of neurodegeneration in Alzheimer's disease

D. Jones, V Lowe, J. Graff-Radford, H. Botha, L. Barnard, D. Wiepert, M. C. Murphy, M. Murray, M. Senjem, J. Gunter, H. Wiste, B. Boeve, D. Knopman, R. Petersen, C. Jack

Summary: This study presents a model of the association between dementia symptoms and degenerative brain anatomy using F18-fluorodeoxyglucose PET and dimensionality reduction techniques. The authors propose a global information processing model for mental functions that links neuroanatomy, cognitive neuroscience and clinical neurology. They also apply the model to normal aging and other degenerative diseases of mental functions.

NATURE COMMUNICATIONS (2022)

Article Neurosciences

Neuropathology of Parkinson's disease after focused ultrasound thalamotomy

Shunsuke Koga, Mariam Ishaque, W. Jeffrey Elias, Binit B. Shah, Aya Murakami, Dennis W. Dickson

Summary: This study reports the first postmortem neuropathologic findings of FUS thalamotomy in a patient with tremor-dominant PD. The results suggest that FUS thalamotomy can improve tremor symptoms and cause thalamic lesions, with implications for understanding PD-related pathology. Further pathological assessments are needed.

NPJ PARKINSONS DISEASE (2022)

Article Clinical Neurology

Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI

Aivi T. Nguyen, Naomi Kouri, Sydney A. Labuzan, Scott A. Przybelski, Timothy G. Lesnick, Sheelakumari Raghavan, Robert Reid, R. Ross Reichard, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Michelle M. Mielke, Dennis W. Dickson, Jonathan Graff-Radford, Melissa E. Murray, Prashanthi Vemuri

Summary: This study evaluated the association between neuroimaging measures of cerebrovascular disease (CVD) and neuropathologic CVD scales, finding that dMRI could serve as a meaningful surrogate for CVD assessment and suggesting the development of better quantitative measures using dMRI.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain

Christina M. Moloney, Sydney A. Labuzan, Julia E. Crook, Habeeba Siddiqui, Monica Castanedes-Casey, Christian Lachner, Ronald C. Petersen, Ranjan Duara, Neill R. Graff-Radford, Dennis W. Dickson, Michelle M. Mielke, Melissa E. Murray

Summary: This study aims to characterize the recognition of phosphorylated tau sites in early neurofibrillary tangle maturity levels, which may explain why these fluid biomarkers can be observed before symptom onset.

ALZHEIMERS & DEMENTIA (2023)

Article Chemistry, Organic

Comparison of [18F]F-CNBI and [18F]F-CNPIFE as Positron Emission Tomography Probes for Noninvasive Imaging of Glycogen Synthase Kinase-3 in Normal Mice

Heather M. Stein, Surendra R. Gundam, Aditya Bansal, Nicholas R. Nelson, Geoffry L. Curran, Timothy R. DeGrado, Mark A. Frye, John D. Port, Val J. Lowe, Melissa E. Murray, Mukesh K. Pandey

Summary: This study synthesized two PET probes and evaluated their permeability through the blood-brain barrier and affinity towards GSK-3 alpha/beta. The results showed that [F-18]F-CNPIFE had higher brain uptake compared to [F-18]F-CNBI, making it a promising PET probe for imaging GSK-3 alpha/beta.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2023)

Article Neurosciences

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Jaclyn Lilek, Kaouther Ajroud, Alexander Z. Feldman, Sesha Krishnamachari, Shadi Ghourchian, Tamar Gefen, Callen L. Spencer, Allegra Kawles, Qinwen Mao, Jessica F. Tranovich, Clifford R. Jack, M-Marsel Mesulam, R. Ross Reichard, Hui Zhang, Melissa E. Murray, David Knopman, Dennis W. Dickson, Ronald C. Petersen, Benjamin Smith, Karen H. Ashe, Michelle M. Mielke, Kathryn M. Nelson, Margaret E. Flanagan

Summary: Phosphorylated cytoplasmic tau inclusions are correlated with and precede cognitive deficits in Alzheimer's Disease (AD). The results also indicate that the frontal cortex represents early AD, while entorhinal total tau levels are significantly higher in amnestic mild cognitive impairment compared to AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Neurosciences

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins

Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, Minerva M. Carrasquillo, Xue Wang, Chia-Chen Liu, Yu Yamazaki, Thuy T. Nguyen, Kimberly Malphrus, Michael Heckman, Kristi Biswas, Kwangsik Nho, Matthew Baker, Yuka A. Martens, Na Zhao, Jun Pyo Kim, Shannon L. Risacher, Rosa Rademakers, Andrew J. Saykin, Michael DeTure, Melissa E. Murray, Takahisa Kanekiyo, Dennis W. Dickson, Guojun Bu, Mariet Allen, Niluefer Ertekin-Taner

Summary: By integrating genetic information and data on neurobiochemical markers, we identified seven novel loci and the APOE locus that are associated with Alzheimer's disease. These loci and genes are also related to other relevant variables, gene expression, brain health, and other neuropsychiatric diseases.

MOLECULAR NEURODEGENERATION (2023)

Article Clinical Neurology

Creutzfeldt-Jakob Disease Misdiagnosed as Multiple System Atrophy

Nicholas B. B. Martin, Shunsuke Koga, Brian S. S. Appleby, Hiroaki Sekiya, Dennis W. Dickson

Summary: Two cases of patients who were misdiagnosed with multiple system atrophy (MSA) actually had Creutzfeldt-Jakob disease (CJD), as confirmed by neuropathological findings. This suggests that when the disease progresses rapidly or the clinical course is atypical, even if clinical features suggest MSA, the possibility of CJD should also be considered.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Letter Clinical Neurology

The frequency and distribution of TDP-43 pathology in argyrophilic grain disease

Shunsuke Koga, Aya Murakami, Nicholas B. Martin, Dennis W. Dickson

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Clinical Neurology

Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank

Hiroaki Sekiya, Shunsuke Koga, Aya Murakami, Miki Kawazoe, Minji Kim, Nicholas B. Martin, Ryan J. Uitti, William P. Cheshire, Zbigniew K. Wszolek, Dennis W. Dickson

Summary: The study compared the diagnostic accuracy of the MDS criteria and second consensus criteria for MSA, finding that the MDS criteria had higher specificity for clinically established and probable MSA, while the second consensus criteria had higher sensitivity for probable and possible MSA.

NEUROLOGY (2023)

Article Multidisciplinary Sciences

Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation

Junhao Li, Manoj K. Jaiswal, Jo-Fan Chien, Alexey Kozlenkov, Jinyoung Jung, Ping Zhou, Mahammad Gardashli, Luc J. Pregent, Erica Engelberg-Cook, Dennis W. Dickson, Veronique V. Belzil, Eran A. Mukamel, Stella Dracheva

Summary: The repeat expansion in the C9orf72 gene is a common genetic cause of ALS and FTD. The study found pervasive alterations in gene expression and chromatin accessibility in neurons and astrocytes of C9-ALS patients, as well as gene expression changes in glial cells of C9-FTD patients. These findings indicate unique molecular disruptions in different cell types, brain regions, and diseases.

NATURE COMMUNICATIONS (2023)

Article Genetics & Heredity

Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease

Aimee R. Herdt, Hui Peng, Dennis W. Dickson, Todd E. Golde, Elizabeth A. Eckman, Chris W. Lee

Summary: Krabbe disease is a neurologic disorder characterized by the accumulation of psychosine in the CNS. In a mouse model, treatment with AAV1-GALC, a viral vector expressing GALC, significantly improved body weight gain and survival, as well as normalized psychosine levels in the brain.

GENES (2023)

Letter Clinical Neurology

Progressive supranuclear palsy can mimic idiopathic normal pressure hydrocephalus: A case series

Miki Kawazoe, Shunsuke Koga, Dennis W. Dickson

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

No Data Available